Sunday, September 13, 2026

Febrile Seizures and Antipyretics

Febrile Seizures and Antipyretics

Febrile Seizures and Antipyretics

Clinical Bottom Line

  • These notes apply primarily to a neurologically healthy child who has returned to baseline after a simple febrile seizure.
  • Simple febrile seizures usually have an excellent prognosis. Evaluation should focus on the cause of the fever and on excluding central nervous system infection when clinically indicated.
  • Acetaminophen or ibuprofen may be used to relieve pain or distress. They should not be prescribed or scheduled with the promise that they will prevent a febrile seizure during a future febrile illness.
  • A single open-label randomized trial found fewer recurrent seizures during the same fever episode with a specific rectal acetaminophen regimen. Important design and generalizability limitations prevent this result from supporting routine scheduled antipyretic prophylaxis at home.
  • Routine long-term or intermittent antiseizure prophylaxis is not recommended after simple febrile seizures because treatment harms generally outweigh the limited clinical benefit of preventing a usually benign recurrence.

1. Definitions and Scope

  • A febrile seizure is a seizure associated with fever in a young child without central nervous system infection, a major metabolic disturbance, or a prior afebrile seizure.
  • The American Academy of Pediatrics (AAP) guideline population is 6 through 60 months of age.
  • A simple febrile seizure has all of the following features:
    • Generalized onset
    • Duration shorter than 15 minutes
    • No recurrence within 24 hours
    • Complete clinical recovery without a persistent focal neurologic deficit
  • A seizure is complex if it is focal, lasts 15 minutes or longer, or recurs within 24 hours.
  • Children younger than 6 months, children outside the usual febrile-seizure age range, and children with an atypical course require reconsideration of the diagnosis and cause.
  • These simple and complex labels describe seizure features. They do not replace assessment for meningitis, encephalitis, toxic or metabolic causes, trauma, epilepsy, or other serious illness.

2. Initial Emergency Department Priorities

  • During an active seizure:
    • Protect the airway and assess breathing and circulation.
    • Place the child in a safe lateral position when practical.
    • Remove nearby hazards.
    • Do not restrain the child and do not place anything in the mouth.
    • Record the seizure duration and observed focal features.
    • Treat a prolonged ongoing seizure according to the local pediatric seizure protocol.
  • After the seizure stops:
    • Confirm recovery toward the neurologic baseline.
    • Look for the source of fever.
    • Assess for meningitis, encephalitis, sepsis, toxic exposure, hypoglycemia, electrolyte disturbance, trauma, and other alternative diagnoses when suggested by the history or examination.

3. Diagnostic Testing After a Simple Febrile Seizure

  • A well-appearing child who has returned to baseline after a simple febrile seizure generally does not need tests solely because the seizure occurred.
  • Routine electroencephalography, blood testing, computed tomography, and magnetic resonance imaging are not indicated for an otherwise typical simple febrile seizure.
  • Testing should instead be driven by the suspected cause of fever and by specific clinical abnormalities.
  • Lumbar puncture should be performed when signs or symptoms raise concern for meningitis.
  • The 2011 AAP guideline states that lumbar puncture is an option for a child 6 to 12 months of age with incomplete or unknown Haemophilus influenzae type b or pneumococcal immunization, and for a child pretreated with antibiotics that may mask meningitis.
  • The AAP documents from 2008 and 2011 are historical guidelines with automatic expiration language. Their major conclusions remain consistent with current NICE guidance, the 2023 Japanese Society of Child Neurology guideline, and a 2024 AAP policy statement that routine neuroimaging is unnecessary after a simple febrile seizure.

4. Prognosis and Recurrence Counseling

  • Febrile seizures occur in approximately 2% to 5% of children in the usual age range.
  • Nearly all neurologically healthy children with simple febrile seizures have an excellent outcome.
  • Historical AAP estimates suggest recurrence in approximately:
    • 50% of children whose first febrile seizure occurs before 12 months of age
    • 30% of children whose first febrile seizure occurs after 12 months of age
    • 50% of children who have already had a second febrile seizure
  • A simple febrile seizure is not the same as epilepsy.
  • The subsequent epilepsy risk is low after a simple febrile seizure, although estimates vary with follow-up duration and patient characteristics.
  • Risk is higher when complex features, preexisting neurodevelopmental abnormalities, or a family history of epilepsy are present.
  • No evidence shows that preventing recurrent simple febrile seizures prevents later epilepsy or improves cognition, school performance, behavior, or survival.

5. What Antipyretics Can and Cannot Do

  • Appropriate purpose:
    • Reduce pain, discomfort, or distress associated with fever.
  • Inappropriate promise:
    • Prevent a febrile seizure during a future febrile illness.
  • NICE guidance states that antipyretics do not prevent febrile convulsions and should not be used specifically for that purpose.
  • The 2023 Japanese Society of Child Neurology guideline similarly recommends against antipyretics for prevention of recurrence during a later febrile illness. It permits their usual use to relieve discomfort.
  • Families should not be instructed to wake a comfortable sleeping child solely to administer an antipyretic on a fixed schedule for seizure prevention.
  • Antipyretic selection and dosing should follow the child's weight, age, contraindications, product instructions, and local prescribing guidance. Avoid duplicate acetaminophen-containing products and dosing errors.

6. Evidence Across Separate Febrile Illnesses

  • Randomized trials of acetaminophen, ibuprofen, or diclofenac-based regimens have not demonstrated prevention of recurrent febrile seizures during later febrile illnesses.
  • A 2021 Cochrane review included 32 randomized or quasi-randomized trials involving 4,431 children across prophylactic interventions.
  • For intermittent ibuprofen compared with placebo, no significant recurrence reduction was found at 6, 12, or 24 months.
  • A 2021 systematic review and meta-analysis reported no evidence of benefit for antipyretic prophylaxis during distant fever episodes. Its pooled estimate from 2 randomized trials was an odds ratio of 0.92 (95% confidence interval 0.57 to 1.48).
  • This evidence supports a clear counseling statement: treating discomfort is reasonable, but fever control cannot be relied upon to prevent the next febrile seizure.

7. Evidence During the Same Fever Episode

Murata et al, 2018

  • Design:
    • Single-center, prospective, open-label randomized trial in Japan
    • Children 6 to 60 months of age presenting after a febrile seizure
    • 423 children analyzed: 219 in the acetaminophen group and 204 in the control group
  • Intervention:
    • Rectal acetaminophen 10 mg/kg on arrival, then every 6 hours when temperature remained above 38.0 degrees C
    • Continued until 24 hours after the first seizure
    • The control group received no antipyretic and no placebo during that interval
  • Result:
    • Same-episode seizure recurrence occurred in 9.1% of the acetaminophen group and 23.5% of controls
    • Absolute risk reduction was 14.4 percentage points
    • The approximate number needed to treat was 7, calculated from the reported event rates
  • Major limitations:
    • Single center
    • Open label
    • No placebo control
    • Rectal regimen rather than usual oral home treatment
    • Substantial exclusions, including children who had already received rectal diazepam and children with diarrhea
    • Randomized participants were excluded from the final analysis, so the analysis was not a complete intention-to-treat analysis
    • The control condition of no antipyretic may not represent routine practice
  • Interpretation:
    • The trial suggests a possible reduction in another seizure within the same fever episode under a specific monitored regimen.
    • It does not show that routine oral antipyretics prevent seizures during later illnesses.
    • It does not justify promising seizure prevention or automatically prescribing scheduled home antipyretics after every simple febrile seizure.
    • The 2023 Japanese guideline reviewed this finding but still did not recommend antipyretics for prevention of same-episode recurrence.

8. Antiseizure Prophylaxis

  • Intermittent diazepam and continuous phenobarbital can reduce recurrence in some trials.
  • Adverse effects are common and may include sedation, ataxia, irritability, and impaired assessment of a child with evolving central nervous system infection.
  • Because recurrent simple febrile seizures are usually benign, the AAP and Cochrane review conclude that routine continuous or intermittent antiseizure prophylaxis is not justified for most children.
  • Acute rescue medication for an ongoing prolonged seizure is a separate indication and should follow an individualized emergency plan.
  • Atypical, prolonged, focal, or recurrent events and cases involving substantial family anxiety may warrant follow-up with pediatrics or pediatric neurology.

9. Caregiver First-Aid Script

  • Place the child on the side on a safe surface.
  • Move hard or sharp objects away.
  • Do not hold the child down.
  • Do not place a spoon, finger, medication, or other object in the mouth.
  • Time the seizure and observe whether movements are generalized or focal.
  • Call emergency medical services immediately if the seizure continues, breathing is abnormal, cyanosis develops, serious illness is suspected, or the child does not progressively recover after the seizure.
  • Seek repeat clinical assessment for another seizure in the same 24-hour period, an atypical event, or a child outside the usual age range.
  • Follow the local institution's approved seizure and emergency-call instructions. A fixed time threshold should not delay help when breathing or recovery is abnormal.

10. Suggested Family Explanation

Your child has returned to normal and today's event fits a simple febrile seizure. These seizures are common in young children and usually have an excellent outcome. Another seizure may occur during this illness or with a later fever, but this does not mean your child has epilepsy. Acetaminophen or ibuprofen can be used when your child is uncomfortable, but they cannot reliably prevent another febrile seizure. If another seizure occurs, place your child on the side, do not put anything in the mouth, and time the event. Call emergency services if the seizure continues, breathing is abnormal, the lips turn blue, or recovery does not progress normally.

11. Key Teaching Distinction

  • Future febrile illnesses: antipyretics do not prevent recurrent febrile seizures.
  • Same fever episode: one limited trial suggests possible benefit from a specific rectal acetaminophen regimen, but the evidence is insufficient for routine prophylaxis.
  • Routine practice: use antipyretics for comfort, not as seizure-prevention therapy.

References

  1. Hou EM. Pediatric febrile seizures: caregiver education and evidence for antipyretic prevention. 2026. https://hou-em.netlify.app/febrile-seizure-antipyretics/
  2. American Academy of Pediatrics, Subcommittee on Febrile Seizures. Febrile seizures: clinical practice guideline for the long-term management of the child with simple febrile seizures. Pediatrics. 2008;121(6):1281-1286. doi:10.1542/peds.2008-0939.
  3. American Academy of Pediatrics, Subcommittee on Febrile Seizures. Febrile seizures: guideline for the neurodiagnostic evaluation of the child with a simple febrile seizure. Pediatrics. 2011;127(2):389-394. doi:10.1542/peds.2010-3318.
  4. American Academy of Pediatrics. Optimizing advanced imaging of the pediatric patient in the emergency department: policy statement. Pediatrics. 2024;154(1):e2024066854. AAP policy statement.
  5. National Institute for Health and Care Excellence. Fever in under 5s: assessment and initial management. NG143. Recommendation 1.6.1. NICE recommendations.
  6. Japanese Society of Child Neurology. Clinical practice guideline for febrile seizures 2023. Section 6, CQ6-1. Guideline PDF.
  7. Offringa M, Newton R, Nevitt SJ, Vraka K. Prophylactic drug management for febrile seizures in children. Cochrane Database Syst Rev. 2021;6:CD003031. doi:10.1002/14651858.CD003031.pub4.
  8. Murata S, Okasora K, Tanabe T, et al. Acetaminophen and febrile seizure recurrences during the same fever episode. Pediatrics. 2018;142(5):e20181009. doi:10.1542/peds.2018-1009.
  9. Hashimoto R, Suto M, Tsuji M, et al. Use of antipyretics for preventing febrile seizure recurrence in children: a systematic review and meta-analysis. Eur J Pediatr. 2021;180(4):987-997. doi:10.1007/s00431-020-03845-8.

Clinical education note for health professionals. This document is not a substitute for current institutional protocols or patient-specific medical judgment.

Diabetic Ketoacidosis Management

Diabetic Ketoacidosis: Treat Ketones, Not Just Glucose Diabetic Ketoacidosis: Treat Ketones, Not Just Glucose Diagnostic...